Caplin Point Laboratories Ltd.

View in App
808.85 +31.30 ▲4.0%

08 June 2023, 04:01:00 PM
Volume: 63,152

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.caplinpoint.net
Market Cap 6,141.90 Cr.
Enterprise Value(EV) 5,651.83 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 49.55 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 16.32 Trailing Twelve Months Ending 2023-03
Industry PE 33.63 Trailing Twelve Months Ending 2023-03
Book Value / Share 247.65 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.27 Calculated using Price: 808.85
Dividend Yield 0.25 Period Ending 2022-03
No. of Shares Subscribed 7.59 Cr. 75,933,746 Shares
FaceValue 2
About Caplin Point Laboratories Ltd.
Caplin Point is the mid-sized company in India's pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.

Caplin Point Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Caplin Point Laboratories Ltd. Performance

View details >>
1 Day
+4.03%
1 Week
+6.91%
1 Month
+17.94%
3 Month
+22.35%
6 Month
+8.50%
1 Year
+6.24%
2 Year
+35.13%
5 Year
+68.44%
10 Year
+6519.07%

Caplin Point Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2014-06 2015-06 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 53.24 55.78 43.13 54.97 49.43 37.14 29.58 25.65 24.71
Return on Capital Employed (%) 68.99 71.11 55.41 69.03 64.08 45.59 33.35 28.82 28.77
Return on Assets (%) 16.48 20.12 18.46 30.54 33.68 28.41 23.02 20.20 19.94

Caplin Point Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 62 93 128 225 364 633 948 1,186 1,484 1,880
Non Curr. Liab. 10 10 14 20 28 23 25 17 13 2
Curr. Liab. 108 125 125 113 109 86 144 143 208 268
Minority Int. 0 0 0 0 0 0 9 18 26 27
Equity & Liab. 180 229 267 358 500 743 1,126 1,364 1,730 2,178
Non Curr. Assets 131 147 149 179 196 249 303 349 432 623
Curr. Assets 49 82 119 179 304 494 823 1,015 1,298 1,554
Misc. Exp. not W/O
Total Assets 180 229 267 358 500 743 1,126 1,364 1,730 2,178

Caplin Point Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 173 252 239 402 540 649 863 1,061 1,269 1,467
Other Income 4 3 4 10 13 19 41 28 39 56
Total Income 177 255 242 412 553 668 905 1,089 1,308 1,523
Total Expenditure -137 -192 -175 -277 -345 -417 -603 -737 -875 -1,026
PBIDT 40 63 68 135 208 251 301 352 433 497
Interest -1 -1 0 -1 -1 -1 0 -2 -1 -1
Depreciation -4 -8 -7 -13 -19 -23 -32 -37 -47 -45
Taxation -10 -12 -14 -25 -44 -50 -54 -62 -77 -74
Exceptional Items
PAT 26 41 46 96 145 177 215 251 308 377
Minority Interest 0 0 0 0 0 -9 -9 -1
Share Associate 0
Other Related Items
Consolidated Net Profit 26 41 46 96 145 177 215 242 300 376
Adjusted EPS 3 5 6 13 19 23 28 32 40 50

Caplin Point Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2013-06 Rs. Cr. 2014-06 Rs. Cr. 2015-06 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 32 60 50 42 68 66 83 45 269 337
Cash Fr. Inv. -45 -44 -23 -6 -36 -69 -100 -55 -29 -271
Cash Fr. Finan. -1 -6 -9 -14 -7 -12 90 80 -24 -41
Net Change -15 10 19 23 25 -14 73 70 215 25
Cash & Cash Eqvt 17 27 45 68 91 77 151 221 436 461

Caplin Point Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 69.03 69.03 69.03 68.91 68.89 68.88 68.88 68.80 70.66
Public 30.97 30.97 30.97 31.09 31.11 31.12 31.12 31.20 29.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Caplin Point Laboratories Ltd. Announcements

View details >>
Thu, 08 Jun 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that mentioned share certificate has been reported as lost by the shareholder of the Company.
Fri, 02 Jun 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
In continuation of our letter dated May 22 2023 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the transcript of the presentation made on Saturday May 27 2023 on audited Financial Results (Consolidated and Standalone) of the Company for the quarter and year ended March 31 2023 is available on the Companys website
Thu, 01 Jun 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi

Caplin Point Laboratories Ltd. Technical Scans

View details >>
Thu, 08 Jun 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High

Caplin Point Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,838.35 987.10 -2.7%
Divi's Laboratories Ltd. 92,904.71 3,499.65 -1.2%
Cipla Ltd. 77,933.48 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. 77,407.40 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. 70,853.48 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. 60,810.18 1,802.05 +0.0%
Mankind Pharma Ltd. 58,347.71 1,464.00 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.95 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2023-03 50.95 3,499.65 -1.2%
Cipla Ltd. Consolidated 2023-03 27.81 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.18 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.49 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.99 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2023-03 45.75 1,464.00 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,499.65 -1.2%
Cipla Ltd. Consolidated 2023-03 3.33 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.33 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.45 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.84 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2023-03 4.99 1,464.00 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,464.00 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,464.00 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,464.00 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,464.00 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,464.00 -1.5%

Caplin Point Laboratories Ltd. FAQ's

What is Caplin Point Lab share price?
Can I buy Caplin Point Lab shares now?
What is the Dividend Yield of Caplin Point Lab?
What is the Market Cap of Caplin Point Lab?
What are the key metrics to analyse Caplin Point Lab?
What is the 52 Week High and Low of Caplin Point Lab?
What is the trend of Caplin Point Lab share price?